03 August 2012
High consumption of vitamin E, either by dietary means or from supplement use, may lower the risk of liver cancer according to a new study from China.
To determine a potential relationship between vitamin E intake and liver cancer risk, the observational study analyzed the dietary habits of 132,837 middle-aged or older Chinese participants and cases of liver cancer that developed between two years after the start of the study and an average of further 11 years for women and 5 years for men (1). The study results showed that an increased vitamin E intake by dietary means and taking vitamin E supplements were both associated with a lower risk of liver cancer.
The researchers commented that they found a clear relationship between the dose of antioxidant vitamin E intake and the magnitude of disease risk reduction. Liver cancer is the third most common cause of cancer mortality in the world, the fifth most common cancer found in men and the seventh most common in women. Approximately 85% of liver cancers occur in developing nations, with 54% in China alone. Epidemiological studies that examined the relationship between vitamin E intake and liver cancer have produced inconsistent results in the past.
9 January 2013
According to a new review, many sections of the population are still not getting enough vitamin D despite opportunities for enhancing intakes via fortified foods and supplements.
11 January 2016
Dr. Andrew Chen, MBBS, from the Royal Prince Alfred Hospital at the University of Sydney in Australia and leader of the ONTRAC (Oral Nicotinamide to Reduce Actinic Cancer) phase 3 trial (1), says that “nicotinamide presents a new opportunity for the chemoprevention of non-melanoma skin cancers that is readily translatable into clinical practice.” Results from the ONTRAC trial with a cohort of 386 Australian adults indicate that a daily intervention dose of 500 mg nicotinamide (vitamin B3) for 12 months is protective against new cases of non-melanoma skin cancers.
